The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive care, and follow-up for patients with myeloma.
Join Jill Burke, MSN, NP, and Noopur Raje, MD, from Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.
This information was originally presented at the NCCN 2017 Nursing Forum: Oncology Nursing in Hematologic Malignancies held in San Francisco, California, on October 6, 2017.
Join Jill Burke, MSN, NP, and Noopur Raje, MD, from Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.
This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.
The goal of this program is to ensure that members of multidisciplinary teams, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with m
Facebook
Twitter
LinkedIn
Forward
